染色体重塑增强了HAM中的MAP3K8表达:这是治疗干预的关键病原体
Makoto Nakashima1, Kaho Nagai2, Naoki Takao3
1Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kanagawa, Japan.
Nature communications
|November 10, 2025
概括
人类T细胞白血病病毒1型关联骨髓病 (HAM) 涉及T助手1类细胞转化和炎症. 研究人员将MAP3K8确定为关键驱动因素,建议MAP3K8-MEK-ERK通路作为HAM.的潜在治疗标.
科学领域:
- 神经免疫学 神经免疫学
- 分子病毒学分子病毒学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 人类T细胞白血病病毒1型关联骨髓病变 (HAM) 是一种严重的神经炎症疾病,缺乏有效的治疗方法.
- HAM的一个关键特征是感染的T细胞异常分化成T辅助1型 (Th1) 样细胞,导致过度的干扰素 (IFN-γ) 生产和慢性炎症.
- 驱动Th1-样细胞转化和HAM持续炎症的精确分子机制尚未完全理解.
研究的目的:
- 调查染色质重塑在HAM病变发生中的作用.
- 确定关键的分子参与者和参与HAM特征性炎症的信号通路.
- 探索HAM.的潜在治疗点.
主要方法:
- 在与HTLV-1相关的疾病中,采用了转录基因分析和染色质可访问性分析.
- 进行生物标志物评估以评估炎症概况.
- 使用ex vivo培养试验来测试MEK抑制剂的疗效.
主要成果:
- MAP3K8被确定为定义HAM.的炎症特征的关键基因.
- 发现MAP3K8过度表达促进了Th1-like分化,并激活了MEK-ERK信号通路.
- HTLV-1 Tax,Fosl2和c-Jun被证明可以协同诱导MAP3K8增强剂的染色质重塑,从而导致其过度表达.
- 在ex vivo模型中,MEK抑制剂成功抑制了MAP3K8-MEK-ERK级联并减少了炎症.
结论:
- 由HTLV-1蛋白驱动的MAP3K8位点的异常染色体重塑在HAM病原发生过程中起着中心作用.
- MAP3K8-MEK-ERK信号轴是HAM中Th1-样细胞转化和炎症的关键调解器.
- 用MEK抑制剂向MAP3K8-MEK-ERK通路,为HAM提供了一个有前途的治疗策略.
相关概念视频
Chromatin Modification in iPS Cells
2.1K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.1K
Nucleosome Remodeling
10.7K
Nucleosomes are the basic units of chromatin compaction. Each nucleosome consists of the DNA bound tightly around a histone core, which makes the DNA inaccessible to DNA binding proteins such as DNA polymerase and RNA polymerase. Hence, the fundamental problem is to ensure access to DNA when appropriate, despite the compact and protective chromatin structure.
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
10.7K
Spreading of Chromatin Modifications
9.3K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
9.3K
Chromatin Structure Regulates pre-mRNA Processing
8.1K
In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
The chromatin structure, especially...
8.1K
MAPK Signaling Cascades
7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K


